Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Preclinical CRO
Sort By
Newest First
1 / 1
1 / 1
Bioassays
State-of-the-Art, Multi-Modality Bioanalysis in Brisbane
Resolian
PAO-11-24-RTM-04
Nov 12, 2024
Commercialization
Development Strategies for Overcoming Commercialization Challenges
Matthias Lucke, Ph.D.
Coriolis Pharma
PAO-09-24-CL-10
Sep 17, 2024
Recombinant Antibody
Recombinant Antibody Technology is Crucial to Past and Future Success in Biopharma
Suranjana Sen, Ph.D.
Sino Biological
PAO-01-24-CL-4
Jan 24, 2024
Insect Cell Expression
Innovations in Baculovirus–Insect Cell Expression Systems
Amy Sheng, Ph.D.; Yingmin Zhu, Ph.D.; Xuejiao Zhang, Ph.D.
Sino Biological
PAO-09-23-CL-01
Aug 31, 2023
Preclinical Data
Transforming Drug Development with Frictionless Access to Real-Time Preclinical Data
Mark Mintz; Kristen M. Eisenhauer
Charles River Laboratories
PAO-05-23-CL-03
May 05, 2023
Gene Tools
Unlocking New Possibilities in Research, Therapeutics, and Beyond with Morpholino Antisense Oligos
David Alvaro, Ph.D.; Jon Moulton, Ph.D.
Pharma's Almanac
PAO-01-23-CL-05
Feb 01, 2023
Artificial Intelligence in Antibody Design
Accelerated and Cost-Effective Antibody Design Using Artificial Intelligence
Sumana Sundaramurthy, Ph.D.
Sino Biological
PAO-11-022-CL-15
Jan 10, 2023
Computational Drug Design
Integrating Experimental Data and Artificial Intelligence to Accelerate Drug Discovery
Ronald Dorenbos, Ph.D.; Guido Lanza
Charles River Laboratories
PAO-11-022-CL-11-180
Dec 07, 2022
Multispecific Antibodies
Optimized Multispecific Antibody Design, Development, and Manufacturing
Sino Biological
PAO-08-022-CL-04
Aug 22, 2022
Recombinant Antibodies
Taking a Customer-Focused Approach to Custom Antibody Development and Manufacturing
Rob Burgess, Ph.D.; Amy Sheng, Ph.D.; Lilith Elmore
Sino Biological
PAO-04-022-CL-01
Apr 07, 2022
Tissue Models
Accurately Recapitulating Environmental Niches in In Vitro Models of the Intestine
Liz Boazak, Ph.D.
Altis Biosystems
PAO-03-21-CL-01
Mar 11, 2021
Tissue Models
Developing a Robust In Vitro Intestinal Model for Preclinical Candidate Screening of GI Toxicity
Ron Laethem, Ph.D.
Altis Biosystems
PAO-02-21-CL-04
Feb 18, 2021
Tissue Models
Recapitulating the Multifaceted Inflammatory Environment of the Intestine In Vitro
Bailey Zwarycz, Ph.D
Altis Biosystems
PAO-02-21-CL-01
Feb 04, 2021
Preclinical
Increasing the Efficiency of Drug Development with Preclinical Testing Using Human Intestinal Stem Cells
Ron Laethem, Ph.D.
Altis Biosystems
PAO-11-20-CL-01
Dec 09, 2020
Drug Discovery
A Research Partner With Proven Results
Daniel Conlon
IRBM
PAP-Q1-2019-CL-038
Mar 12, 2019